CD55 抗体
Our Local Distributor
北京 101111
Quick Overview for CD55 抗体 (ABIN2191983)
抗原
See all CD55 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
过滤
- 0.2 μm filtered
-
-
-
-
应用备注
- For flow cytometry and Western blotting dilutions to be used depend on detection system applied. It is recommended that users test the reagent and determine their own optimal dilutions. The typical starting working dilution is 1:10.
-
限制
- 仅限研究用
-
-
-
缓冲液
- PBS, containing 0.1 % bovine serum albumin and 0.02 % sodium azide.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C
-
储存方法
- Product should be stored at 4 °C. Under recommended storage conditions, product is stable for one year.
-
有效期
- 12 months
-
-
- CD55 (Complement Decay-Accelerating Factor (CD55))
-
别名
- Cd55, Daf
-
背景
- CD55, also designated decay accelerating factor (DAF), is a 60-70 kDa glycosyl-phosphatidylinositol (GPI) anchored protein. CD55 is a member of the family of proteins that protect host tissue from damage by autologous complement. CD55 was first recognized as a species restricting factor operating at the level of C3 activation. It binds C3b and C4b to inhibit formation and half-life of the C3 convertases. CD55 expression increases upon T cell activation and in the presence of phorbol esters antibodies to CD55 (e.g. monoclonal antibody D17) are mitogenic. CD55 is broadly distributed among cells in contact with serum, including both haematopoietic and non- haematopoietic cells. Although CD55 does not have an essential role in controlling hemolysis of erythrocytes, it has an important role in regulation of the deposition of C3 on nucleated cells. Aliases DAF (decay accelerating factor)
-
途径
- Complement System, Regulation of Leukocyte Mediated Immunity
抗原
-